Inventor · disambiguated record
Markus Gude
Also filed as: GUDE MARKUS
28 granted patents·8 pending applications·163 citations·filing 2002–2019
96Inventor score
Files withAISSAOUI HAMED11ACTELION PHARMACEUTICALS LTD8IDORSIA PHARMACEUTICALS LTD7BOSS CHRISTOPH2GUDE MARKUS2
Top patents by PatentIndex Score
36 records- 0192US7994336B2Azetidine compounds as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2007·Granted Aug 9, 2011·23 cites·15 claims
- 0289US8288429B22-aza-bicyclo[3.3.0]octane derivativesAISSAOUI HAMED·Filed 2008·Granted Oct 16, 2012·15 cites·13 claims
- 0388US8236964B2Thiazolidine derivatives as orexin receptor antagonistsAISSAOUI HAMED·Filed 2008·Granted Aug 7, 2012·13 cites·17 claims
- 0488US8106215B23-aza-bicyclo[3.3.0]octane compoundsAISSAOUI HAMED·Filed 2008·Granted Jan 31, 2012·13 cites·15 claims
- 0587US9732075B2Benzimidazole-proline derivativesIDORSIA PHARMACEUTICALS LTD·Filed 2013·Granted Aug 15, 2017·8 cites·12 claims
- 0687US8063099B2Trans-3-aza-bicyclo[3.1.0]hexane derivativesAISSAOUI HAMED·Filed 2008·Granted Nov 22, 2011·7 cites·17 claims
- 0786US8288435B22-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonistsAISSAOUI HAMED·Filed 2007·Granted Oct 16, 2012·11 cites·20 claims
- 0886US7834028B2Pyrazolo-tetrahydro pyridine derivatives as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2007·Granted Nov 16, 2010·9 cites·19 claims
- 0984US10329287B2Benzimidazole-proline derivativesIDORSIA PHARMACEUTICALS LTD·Filed 2017·Granted Jun 25, 2019·3 cites·12 claims
- 1084US8003654B2N-glycinsulfonamide derivatives and uses as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2007·Granted Aug 23, 2011·7 cites·12 claims
- 1183US10023560B2Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonistIDORSIA PHARMACEUTICALS LTD·Filed 2017·Granted Jul 17, 2018·3 cites·13 claims
- 1283US9211279B2Proline sulfonamide derivatives as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2015·Granted Dec 15, 2015·3 cites·30 claims
- 1382US9493446B2Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivativesACTELION PHARMACEUTICALS LTD·Filed 2013·Granted Nov 15, 2016·6 cites·21 claims
- 1481US9790208B2Crystalline salt form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonistIDORSIA PHARMACEUTICALS LTD·Filed 2014·Granted Oct 17, 2017·4 cites·6 claims
- 1581US8895606B2Proline sulfonamide derivatives as orexin receptor antagonistsBOSS CHRISTOPH·Filed 2011·Granted Nov 25, 2014·5 cites·9 claims
- 1680US9000029B2Proline sulfonamide derivatives as orexin receptor antagonistsBOSS CHRISTOPH·Filed 2014·Granted Apr 7, 2015·4 cites·13 claims
- 1780US8133901B23-heteroaryl (amino or amido)-1-(biphenyl or phenylthiazolyl) carbonylpiperidine derivatives as orexin receptor inhibitorsAISSAOUI HAMED·Filed 2007·Granted Mar 13, 2012·4 cites·10 claims
- 1879US8188082B25,6,7,8-tetrahydro-imidazo[1,5-α]pyrazine derivativesAISSAOUI HAMED·Filed 2007·Granted May 29, 2012·8 cites·11 claims
- 1978US9914720B2Crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[D]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonistsIDORSIA PHARMACEUTICALS LTD·Filed 2014·Granted Mar 13, 2018·3 cites·12 claims
- 2078US9914721B2Use of benzimidazole-proline derivativesIDORSIA PHARMACEUTICALS LTD·Filed 2014·Granted Mar 13, 2018·4 cites·14 claims
- 2178US8114867B2Oxazolidinone antibiotic derivativesGUDE MARKUS·Filed 2008·Granted Feb 14, 2012·5 cites·11 claims
- 2273US9428456B21-[m-carboxamido(hetero)aryl-methyl]-heterocyclyl-carboxamide derivativesACTELION PHARMACEUTICALS LTD·Filed 2013·Granted Aug 30, 2016·3 cites·23 claims
- 2371US11040966B2Benzimidazole-proline derivativesIDORSIA PHARMACEUTICALS LTD·Filed 2019·Granted Jun 22, 2021·0 cites·29 claims
- 2468US9303023B2Pyrazole and imidazole derivatives useful as orexin antagonistsBOLLI MARTIN·Filed 2012·Granted Apr 5, 2016·1 cites·12 claims
- 2567US8329706B2Oxazolidinone derivativesAISSAOUI HAMED·Filed 2010·Granted Dec 11, 2012·1 cites·15 claims
- 2655US2011195949A12-benzothiophenyl- and 2-naphthyl-oxazolidinones and their azaisostere analogues as antibacterial agentsACTELION PHARMACEUTICALS LTD·Filed 2009·Application pending·0 cites
- 2750US2011263662A11,2-diamido-ethylene derivatives as orexin antagonistsAISSAOUI HAMED·Filed 2008·Application pending·0 cites
- 2849US2010222328A12-cyclopropyl-thiazole derivativesAISSAOUI HAMED·Filed 2008·Application pending·0 cites
- 2948US2010029617A11,4,5,6,7,8-hexahydro-1,2,5-triaza-azulene derivatives as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 3046US2010016401A13-aza-bicyclo[3.1.0]hexane derivativesACTELION PHAMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 3144US7019002B2Pyridopyrimidinones derivatives as telomerase inhibitorsPHARMACIA & UPJOHN SPA·Filed 2002·Granted Mar 28, 2006·0 cites·9 claims
- 3239US2013096119A1Isoquinolin-3-Ylurea DerivativesBUR DANIEL·Filed 2011·Application pending·0 cites
- 3338US8273740B22-sulfanyl-benzoimidazol-1-yi-acetic acid derivatives as CRTH2 antagonistsFRETZ HEINZ·Filed 2005·Granted Sep 25, 2012·0 cites·14 claims
- 3436US8889676B23-ureidoisoquinolin-8-yl derivativesGUDE MARKUS·Filed 2012·Granted Nov 18, 2014·0 cites·16 claims
- 3536US2012088759A1Thiazolidin-4-one and [1,3]-thiazinan-4-one compounds as orexin receptor antagonistsAISSAOUI HAMED·Filed 2010·Application pending·0 cites
- 3635US2004132807A1Aurones as telomerase inhibitorsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Markus Gude files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →